Skip to main content

Home/ Dr. Goodyear/ Group items tagged advanced glycation end products

Rss Feed Group items tagged

Nathan Goodyear

Advanced glycation end product level, diabetes, an... [Neurology. 2011] - PubMed - NCBI - 0 views

  •  
    diabetes associated with increased advanced glycation end products (AGE) in elderly population.  This increase in AGE associated with cognitive decline as evaluated by MMSE.
Nathan Goodyear

Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Dise... - 0 views

  •  
    AGE's, advanced glycation end products, play a role in development/progression of neurodegenerative diseases such as Alzheimer's, Parkinson's...
Nathan Goodyear

Investigations on oxidativ... [Eur Arch Psychiatry Clin Neurosci. 1999] - PubMed - NCBI - 0 views

  •  
    This study finds that AGE, advanced glycation end products, play a significant role in free radical generation and neurodegenerative disease. Quote: "... pharmacologoical approaches which break the vicious cycle of oxidative stress and neurodegeneration offer new opportunities for the treatment of AD. These approaches include AGE- inhibitors, antioxidants, and anti-inflammatory substances which prevent radical production." They focus on the pharmacological, how about the natural first?
Nathan Goodyear

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease - 0 views

  •  
    NAC shown to improve secondary measures of cognitive function in small study in those with Alzheimer's disease. NAC proves to be a reliable means to reduce free radical induced advanced glycation end productions and resultant inflammation. Also was shown to be well tolerated.
Nathan Goodyear

Regulation of Cyclooxygenase-2 Expression in Monocytes by Ligation of the Receptor for ... - 0 views

  •  
    good article on the biochemistry of COX2 in inflammation.  Particularily with AGE and it the receptors RAGE.  COX2 has been shown to decrease insulin secretion through inhibition of islet cell production, but in the presence of disease level inflammation, COX2 can be a part of a very dangerous autocrine/paracrine loop.
Nathan Goodyear

Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-l... - 0 views

  •  
    Alpha LIpoic Acid inhibits major production of inflammation: NF-KappaB
Nathan Goodyear

Alzheimer's disease--synergistic effects of ... [J Neural Transm. 1998] - PubMed - NCBI - 0 views

  • AGEs are protein modifications that contribute to the formation of the histopathological and biochemical hallmarks of AD: amyloid plaques, neurofibrillary tangles and activated microglia
  •  
    good review of understanding of how poor glucose control, oxidative stress result in AGE and Alzheimer's disease.
1 - 7 of 7
Showing 20 items per page